Kite Pharma, Inc.

September 15, 2017 Kite Pharma, Inc. and its board of directors are facing a proposed class action lawsuit claiming they published a misleading recommendation statement in connection with a potential merger between the company and a subsidiary of Gilead Sciences, Inc.

September 15, 2017 A lawsuit has been filed against Kite Pharma, Inc., its board of directors, Gilead Sciences, Inc., and Dodge Merger Sub, Inc. alleging the defendants issued a misleading registration statement regarding a proposed merger between Kite and Gilead.